Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Further Assessment of 17α-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro

Shu-Ying Chang, Cliff Chen, Zheng Yang and A. David Rodrigues
Drug Metabolism and Disposition August 2009, 37 (8) 1667-1675; DOI: https://doi.org/10.1124/dmd.109.026997
Shu-Ying Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cliff Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zheng Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. David Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 8 1667-1675
DOI 
https://doi.org/10.1124/dmd.109.026997
PubMed 
19454483

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Accepted May 18, 2009
  • Received February 3, 2009
  • Published online July 17, 2009.

Article Versions

  • Earlier version (May 19, 2009 - 06:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Shu-Ying Chang,
  2. Cliff Chen,
  3. Zheng Yang and
  4. A. David Rodrigues
  1. Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey
  1. Address correspondence to:
    Shu-Ying Chang, Bristol-Myers Squibb, 311 Pennington-Rocky Hill Road, NJ 08534. E-mail: shu.chang{at}bms.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 20172139
Sep 201711214
Oct 20173177
Nov 20171168
Dec 20172177
Jan 201802910
Feb 201814313
Mar 201802513
Apr 201832913
May 201832010
Jun 20180186
Jul 2018086
Aug 20180195
Sep 20180111
Oct 20180175
Nov 20180165
Dec 201823137
Jan 20191443
Feb 20191427
Mar 20191396
Apr 20192097
May 2019425
Jun 2019221018
Jul 20191744
Aug 20191324
Oct 20192455
Nov 20191949
Dec 20192144
Jan 20201841
Feb 20202043
Mar 20201213
May 2020810
Jun 20201417
Jul 20201020
Aug 2020511
Sep 20201112
Oct 20201945
Nov 20201413
Dec 20202569
Jan 202117127
Feb 202116114
Mar 20212742
Apr 20212953
May 20211841
Jun 20212853
Jul 20212756
Aug 20212054
Sep 2021730
Oct 20211873
Nov 20213923
Dec 20211812
Jan 20223631
Feb 20222514
Mar 20223443
Apr 20224251
May 20222042
Jun 20221943
Jul 20221227
Aug 20221112

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (8)
Drug Metabolism and Disposition
Vol. 37, Issue 8
1 Aug 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Further Assessment of 17α-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Further Assessment of 17α-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro

Shu-Ying Chang, Cliff Chen, Zheng Yang and A. David Rodrigues
Drug Metabolism and Disposition August 1, 2009, 37 (8) 1667-1675; DOI: https://doi.org/10.1124/dmd.109.026997

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Further Assessment of 17α-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro

Shu-Ying Chang, Cliff Chen, Zheng Yang and A. David Rodrigues
Drug Metabolism and Disposition August 1, 2009, 37 (8) 1667-1675; DOI: https://doi.org/10.1124/dmd.109.026997
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro-In Vivo Extrapolation Using Empirical Scaling
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics